Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptor

Journal of Immunology

Volumn 157, Issue 1, 1996, Pages 386-392

  Araga, Shigeru ^a   Galin, F Shawn ^b   Kishimoto, Masahiro ^a   Adachi, Akiko ^a   Blalock, J Edwin ^b  

^a TOTTORI UNIVERSITY   (Japan)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; EPITOPE; MONOCLONAL ANTIBODY;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; IMMUNIZATION; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; FEMALE; IMMUNIZATION, PASSIVE; IMMUNODOMINANT EPITOPES; MOLECULAR SEQUENCE DATA; MYASTHENIA GRAVIS; PEPTIDES; RATS; RATS, INBRED LEW; RECEPTORS, CHOLINERGIC;

EID: 0030013192     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Smith, L. R., K. L. Bost, and J. E. Blalock. 1987. Generation of idiotypic and anti-idiotypic antibodies by immunization with peptides encoded by complementary RNA: a possible molecular basis for the network theory. J. Immunol. 138:7.
2. Blalock, J. E., J. N. Whitaker, E. N. Benveniste, and K. L. Bost. 1989. Use of peptides encoded by complementary RNA for generating anti-idiotypic antibodies of predefined specificity. Methods Enzymol. 178:63.
3. Blalock, J. E., and K. L. Bost. 1986. Binding of peptides that are specified by complementary RNAs. Biochem. J. 234:679.
4. Clarke, B. L., and J. E. Blalock. 1990. Steroidogenic activity of a peptide specified by the reversed sequence of corticotropin mRNA. Proc. Natl. Acad. Sci. USA 87:9708.
5. Clarke, B. L., and J. E. Blalock. 1991. Characteristics of peptides specified by antisense nucleic acids. In Antisense Nucleic Acids and Proteins: Fundamentals and Applications. A. R. vanderKrol and J. N. M. Mol, eds. Marcel Dekker, New York, p. 169.
6. Weigent, D. A., B. L. Clarke, and J. E. Blalock. 1994. Peptide design using a genetically patterned binary code: growth hormone-releasing hormone as a model. ImmunoMethods 5:91.
7. Blalock, J. E. 1994. Protein configurations. Science 265:1511.
8. Kamtekar, S., J. M. Schiffer, H. Xiong, J. M. Babik, and M. Hecht. 1993. Protein design by binary patterning of polar and nonpolar amino acids. Science 262:1680.
9. Bost, K. L., E. M. Smith, and J. E. Blalock. 1985. Similarity between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA. Proc. Natl. Acad. Sci. USA 82:1372.
10. Jarpe, M. A., and J. E. Blalock. 1994. Complementary peptides: applications of the molecular recognition theory to peptide and protein purification and design. In Peptides: Design, Synthesis, and Biological Activity. C. Basava and G. M. Anantharamiah, eds. Springer-Verlag, New York, p. 165.
11. Maier, C. C., H. N. B. Moseley, S. R. Zhou, J. N. Whitaker, and J. E. Blalock. 1994. Identification of interactive determinants on idiotypic-anti-idiotypic antibodies through comparison of their hydropathic profiles. ImmunoMethods 5:107.
12. Fassina, G., and M. Melli. 1994. Identification of interactive sites of proteins and protein receptors by computer-assisted searches for complementary peptide sequences. ImmunoMethods 5:114.
13. Blalock, J. E., and E. M. Smith. 1984. Hydropathic anti-complementarity of amino acids based on the genetic code. Biochem. Biophys. Res. Commun. 121: 203.
14. Blalock, J. E. 1995. Genetic origins of protein shape and interaction rules. Nature Med. 1:876.
15. Fassina, G., P. P. Roller, A. D. Olson, S. S. Thorgeirsson, and J. G. Omichinski. 1989. Recognition properties of peptides hydropathically complementary to residues 356-375 of the c-raf protein. J. Biol. Chem. 264:11252.
16. Blalock, J. E. 1990. Complementarity of peptides specified by "sense" and "antisense" strands of DNA. Trends Biotech. 8:140.
17. Baranyi, L., W. Campbell, K. Ohshima, S. Fujimoto, M. Boros, and H. Okada. 1995. The antisense homology box: a new motif within proteins that encodes biologically active peptides. Nature Med. 1:894.
18. Ghiso, J., E. Saball, J. Leoni, A. Rostagno, and B. Frangione. 1990. Binding of cystatin C to C4: the importance of sense-antisense peptides in their interaction. Proc. Natl. Acad. Sci. USA 87:1288.
19. Palla, E., G. Bensi, E. Solito, D. T. Buonamassa, G. Gassina, G. Raugei, F. Spano, C. Galeotti, M. Mora, M. Domenighini, M. Rossini, E. Gallo, V. Varinci, M. Bugnoli, F. Bertini, L. Parente, and M. Melli. 1993. Loop substitution as a tool to identify active sites of interleukin-1-beta. J. Biol. Chem. 268:13486.
20. Ruiz-Opazo, N., K. Akimoto, and V. L. M. Herrera. 1995. Identification of a novel dual angiotensin II/vasopressin receptor on the basis of molecular recognition theory. Nature Med. 1:1074.
21. Pascual, D. W., and K. L. Bost. 1989. Anti-peptide antibodies recognize anti-substance P antibodies in an idiotypic fashion. Peptide Res. 2:207.
22. Whitaker, J. N., B. E. Sparks, D. P. Walker, R. Goodin, and E. N. Benveniste. 1989. Monoclonal idiotypic and anti-idiotypic antibodies produced by immunization with peptides specified by a region of human myelin basic protein mRNA and its complement. J. Neuroimmunol. 22:157.
23. Zhou, S. R., and J. N. Whitaker. 1990. An idiotype shared by monoclonal antibodies to different peptides of human myelin basic protein. J. Immunol. 145: 2554.
24. Zhou, S. R., and J. N. Whitaker. 1992. Interstrain cross-reactive idiotypes on monoclonal antibodies to an encephalitogenic myelin basic protein peptide. Clin. Immunol. Immunopathol. 63:74.
25. Zhou, S. R., Q. Han, C. C. LaGanke, and J. N. Whitaker. 1994. Comparison of properties of murine monoclonal anti-idiotypic antibodies generated with idiotype-bearing monoclonal antibodies to myelin basic protein peptides or their complementary peptides. Clin. Immunol. Immunopathol. 70:251.
26. Araga, S., R. D. LeBoeuf, and J. E. Blalock. 1993. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor. Proc. Natl. Acad. Sci. USA 90:8747.
27. Boquet, D., O. Dery, Y. Frobert, J. Grassi, and J. Y. Couraud. 1995. Is hydropathic complementarity involved in antigen-antibody binding? Mol. Immunol. 32:303.
28. Zerari, F., O. Dery, J. Fischer, Y. Frobert, J. Y. Couraud, and M. Conrath. 1995. Ultrastructural study of substance P receptors in the dorsal horn of the rat spinal cord using monoclonal anti-complementary peptide antibody. J. Chem. Neuroanat. 9:65.
29. Zhou, S. R., J. N. Whitaker, and D. Dwyer. 1990. The modulatory effect of anti-idiotypic antibody of hybridoma cells secreting antibody to human myelin basic protein peptide 80-89. J. Neuroimmunol. 29:113.
30. Zhou, S. R., and J. N. Whitaker. 1993. Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies. J. Immunol. 150:1629.
31. Zhou, S. R., J. N. Whitaker, Q. Han, C. Maier, and J. E. Blalock. 1994. A cross-reactive idiotope on T cells from PL/J mice and Lewis rats that recognizes different myelin basic protein encephalilogenic epitopes but is restricted by TCR V β 8.2. J. Immunol. 153:2340.
32. Maier, C. C., F. S. Galin, M. A. Jarpe, P. Jackson, N. R. Krishna, A. M. Gautam, Zhou, SR, J. N. Whitaker, and J. E. Blalock. 1994. A V lambda x-bearing monoclonal antibody with similar specificity and sequence to encephalitogenic T cell receptors. J. Immunol. 153:1132.
33. Zhou, S. R., and J. N. Whitaker. 1994. Use of complementary peptides and their antibodies in T-cell-mediated autoimmune disease: experiments with myelin basic protein. ImmunoMethods 5:136.
34. Patrick, J., and J. Lindstrom. 1973. Autoimmune response to acetylcholine receptor. Science 180:871.
35. Engel, A. G., K. I. Sahashi, and G. Fumigalli. 1981. The immunopathology of acquired myasthenia gravis. Ann. NY Acad. Sci. 377:158.
36. Barkas, T., J. M. Gabriel, A. Mauro, G. J. Hughes, B. Roth, C. Alliod, S. Tzartos, and M. Ballivet. 1988. Monoclonal antibodies to the main immunogenic region of the nicotinic acetylcholine receptor bind to residues 61-76 of the alpha subunit. J. Biol. Chem. 263:5916.
37. Tzartos, S., A. Kokla, S. L. Walgrave, and B. M. Conti-Tronconi. 1988. Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the alpha subunit. Proc. Natl. Acad. Sci. USA 85:2899.
38. Atassi, M. Z., K. H. Ruan, K. Jinnai, M. Oshima, and T. Ashijawa. 1992. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide. Proc. Natl. Acad. Sci. USA 89:5852.
39. Lennon, V. A., and G. E. Griesmann. 1989. Evidence against acetylcholine receptor having a main immunogenic region as a target for autoantibodies in myasthenia gravis. Neurology 39:1069.
40. Tzartos, S. J., D. E. Rand, B. L. Einarson, and J. M. Lindstrom. 1981. Mapping of surface structures on electrophorus acetylcholine receptor using monoclonal antibodies. J. Biol. Chem. 256:8635.
41. Tzartos, S. J., M. E. Seybold, and J. M. Lindstrom. 1982. Specificities of antibodies to acetylcholine receptor in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 79:188.
42. Froehner, S. C., and S. Rafto. 1979. Comparison of the subunits of Torpedo californica acetylcholine receptor by peptide mapping. Biochemistry 18:301.
43. Wofsy, L., and B. Burr. 1969. The use of affinity chromatography for the specific purification of antibodies and antigens. J. Immunol. 103:380.
44. Araga, S., H. Irie, and K. Takahashi. 1985. Analysis of immunoglobulin G/albumin ratios by a competitive ELISA in the serum and in the cerebrospinal fluid of rabbit experimental allergic encephalitis. Jpn. J. Exp. Med. 55:67.
45. Lennon, V. A., J. M. Lindstrom, and M. E. Seybold. 1975. Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs. J. Exp. Med 141:1365.
46. Krolick, K. A., J. W. Uhr, and E. A. Vitetta. 1983. Preparation and application of antibodies coupled to the A chain of ricin. Methods Enzymol. 93:333.
47. Thompson, P. A., S. A. Edlund, and K. A. Krolick. 1995. Identification of an idiotype associated with antibodies responsible for neuromuscular dysfunction in rats with experimental autoimmune myasthenia gravis. Clin. Immunol. Immunopathol. 75:57.
48. Lindstrom, J. L., M. E. Seybold, V. A. Lennon, S. Whittingham, and D. D. Duane. 1976. Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. Neurology 26:1054.
49. Lefvert, A. K., K. Bergstrom, G. Matell, and P. O. Osterman. 1978. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J. Neurol. Neurosurg. Psychiatry 41:394.
50. Limburg, P. C., T. H. T, E. Hummeerl-Tappel, and H. J. G. H. Oosterhuis. 1983. Acetylcholine receptor antibodies in myasthenia gravis. I. Relation to clinical parameters in 250 patients. J. Neurol. Sci. 58:357.
51. Tu, L., and Y. M. Zhang. 1985. Acetylcholine receptor antibodies in myasthenia gravis detected by radioimmunoassay. Clin. J. Neurol. Psychiatry 18:330.
52. Vincent, A., and J. Newson-Davis. 1985. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis results in 153 validated cases and 2,967 diagnostic assays. J. Neurol. Neurosurg. Psychiatry 48:1246.
53. Hohlfeld, R., R. Sterz, I. Kalies, H. Wekerle, and K. Peper. 1983. Experimental myasthenia: lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates. Muscle Nerve 6:160.